Current Status
I am currently being treated for my metastatic cancer with Trodelvy (Sacituzumab Govitecan) plus Ivonescimab. After six cycles, my disease burden has decreased substantially: thoracic lymph nodes show much lower metabolic activity, a tiny liver lesion is no longer visible on MRI but remains low-uptake on PET, and ctDNA has dropped to an extremely low level.
My current challenge is to decide how to move from a strong partial response toward the deepest possible remission, while balancing treatment toxicity, quality of life, CNS surveillance, local therapy options, and personalized immunotherapy strategies. This is my call to the world looking for help, but also to record my journey.